248 related articles for article (PubMed ID: 10505047)
1. The influence of P170-glycoprotein modulators on the efficacy and the distribution of vincristine as well as on MDR1 expression in BRO/mdr1.1 human melanoma xenografts.
Boven E; Jansen WJ; Hulscher TM; Beijnen JH; van Tellingen O
Eur J Cancer; 1999 May; 35(5):840-9. PubMed ID: 10505047
[TBL] [Abstract][Full Text] [Related]
2. Biochemical modulation of 'classical' multidrug resistance by BIBW22BS, a potent derivative of dipyridamole.
Jansen WJ; Pinedo HM; Kuiper CM; Lincke C; Bamberger U; Heckel A; Boven E
Ann Oncol; 1994 Oct; 5(8):733-9. PubMed ID: 7826906
[TBL] [Abstract][Full Text] [Related]
3. CPT-11 sensitivity in relation to the expression of P170-glycoprotein and multidrug resistance-associated protein.
Jansen WJ; Hulscher TM; van Ark-Otte J; Giaccone G; Pinedo HM; Boven E
Br J Cancer; 1998; 77(3):359-65. PubMed ID: 9472629
[TBL] [Abstract][Full Text] [Related]
4. Correlation between functional and molecular analysis of mdr1 P-glycoprotein in human solid-tumor xenografts.
Broxterman HJ; Feller N; Kuiper CM; Boven E; Versantvoort CH; Teerlink T; Pinedo HM; Lankelma J
Int J Cancer; 1995 Jun; 61(6):880-6. PubMed ID: 7790125
[TBL] [Abstract][Full Text] [Related]
5. New highly lipophilic camptothecin BNP1350 is an effective drug in experimental human cancer.
Van Hattum AH; Pinedo HM; Schlüper HM; Hausheer FH; Boven E
Int J Cancer; 2000 Oct; 88(2):260-6. PubMed ID: 11004678
[TBL] [Abstract][Full Text] [Related]
6. Modulator activity of PSC 833 and cyclosporin-A in vincristine and doxorubicin-selected multidrug resistant murine leukemic cells.
Lopes EC; Scolnik M; Alvarez E; Hajos SE
Leuk Res; 2001 Jan; 25(1):85-93. PubMed ID: 11137565
[TBL] [Abstract][Full Text] [Related]
7. Reversal of multidrug resistance in human colon cancer cells expressing the human MDR1 gene by liposomes in combination with monoclonal antibody or verapamil.
Sela S; Husain SR; Pearson JW; Longo DL; Rahman A
J Natl Cancer Inst; 1995 Jan; 87(2):123-8. PubMed ID: 7707383
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of P-glycoprotein transport function and reversion of MDR1 multidrug resistance by cnidiadin.
Barthomeuf C; Grassi J; Demeule M; Fournier C; Boivin D; Béliveau R
Cancer Chemother Pharmacol; 2005 Aug; 56(2):173-81. PubMed ID: 15824923
[TBL] [Abstract][Full Text] [Related]
9. Multidrug resistance gene 1 expression in salivary gland adenocarcinomas and oral squamous-cell carcinomas.
Uematsu T; Hasegawa T; Hiraoka BY; Komatsu F; Matsuura T; Yamada AS; Yamaoka M
Int J Cancer; 2001 Apr; 92(2):187-94. PubMed ID: 11291044
[TBL] [Abstract][Full Text] [Related]
10. Pyramidatine (Z88) Sensitizes Vincristine-Resistant Human Oral Cancer (KB/VCR) Cells to Chemotherapeutic Agents by Inhibition of P-glycoprotein.
Liu Z; Zhu H; Qu S; Tang L; Cao L; Yu W; Yang X; Jiang S; Zhu D; Tan C; Yu L
Anticancer Agents Med Chem; 2018; 18(2):286-294. PubMed ID: 28782465
[TBL] [Abstract][Full Text] [Related]
11. Beta-tubulin and P-glycoprotein: major determinants of vincristine accumulation in B-CLL cells.
Reichle A; Diddens H; Altmayr F; Rastetter J; Andreesen R
Leuk Res; 1995 Nov; 19(11):823-9. PubMed ID: 8551799
[TBL] [Abstract][Full Text] [Related]
12. Modulation of P-glycoprotein mediated drug accumulation in multidrug resistant CCRF VCR-1000 cells by chemosensitisers.
Boer R; Gekeler V; Ulrich WR; Zimmermann P; Ise W; Schödl A; Haas S
Eur J Cancer; 1996 May; 32A(5):857-61. PubMed ID: 9081366
[TBL] [Abstract][Full Text] [Related]
13. Reversal of MDR1/P-glycoprotein-mediated multidrug resistance by vector-based RNA interference in vitro and in vivo.
Shi Z; Liang YJ; Chen ZS; Wang XW; Wang XH; Ding Y; Chen LM; Yang XP; Fu LW
Cancer Biol Ther; 2006 Jan; 5(1):39-47. PubMed ID: 16319528
[TBL] [Abstract][Full Text] [Related]
14. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells.
Stein U; Walther W; Shoemaker RH
J Natl Cancer Inst; 1996 Oct; 88(19):1383-92. PubMed ID: 8827016
[TBL] [Abstract][Full Text] [Related]
15. STI571 combined with vincristine greatly suppressed the tumor formation of multidrug-resistant K562 cells in a human-nude mice xenograft model.
Gao L; Chen L; Fei XH; Qiu HY; Zhou H; Wang JM
Chin Med J (Engl); 2006 Jun; 119(11):911-8. PubMed ID: 16780770
[TBL] [Abstract][Full Text] [Related]
16. P-glycoprotein-mediated acquired multidrug resistance of human lung cancer cells in vivo.
Abe Y; Ohnishi Y; Yoshimura M; Ota E; Ozeki Y; Oshika Y; Tokunaga T; Yamazaki H; Ueyema Y; Ogata T; Tamaoki N; Nakamura M
Br J Cancer; 1996 Dec; 74(12):1929-34. PubMed ID: 8980392
[TBL] [Abstract][Full Text] [Related]
17. Enhancement by recombinant human interferon alfa of the reversal of multidrug resistance by MRK-16 monoclonal antibody.
Fogler WE; Pearson JW; Volker K; Ariyoshi K; Watabe H; Riggs CW; Wiltrout RH; Longo DL
J Natl Cancer Inst; 1995 Jan; 87(2):94-104. PubMed ID: 7707396
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of P-glycoprotein and alterations in topoisomerase II in P388 mouse leukemia cells selected in vivo for resistance to mitoxantrone.
Kamath N; Grabowski D; Ford J; Kerrigan D; Pommier Y; Ganapathi R
Biochem Pharmacol; 1992 Sep; 44(5):937-45. PubMed ID: 1356339
[TBL] [Abstract][Full Text] [Related]
19. [Adenovirus-mediated transfer of anti-MDR1 ribozyme in the treatment of multidrug-resistant human lymphoma in SCID mice].
Xu D; Wang F; Ohnuma T; Jin L
Zhonghua Zhong Liu Za Zhi; 2002 Nov; 24(6):529-32. PubMed ID: 12667317
[TBL] [Abstract][Full Text] [Related]
20. Resistance to the new anti-cancer phospholipid ilmofosine (BM 41 440).
Hofmann J; Utz I; Spitaler M; Hofer S; Rybczynska M; Beck WT; Herrmann DB; Grunicke H
Br J Cancer; 1997; 76(7):862-9. PubMed ID: 9328144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
